Cargando…

Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis

The purpose of this review is to analyse the very large number of studies (sometimes contradictory) on adenoid cystic carcinoma (ACC). This second part provides a critical analysis of various treatment described in the literature. Anywhere the primary tumour is located, the most common treatment for...

Descripción completa

Detalles Bibliográficos
Autor principal: Cantù, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448184/
https://www.ncbi.nlm.nih.gov/pubmed/34533533
http://dx.doi.org/10.14639/0392-100X-N1729
_version_ 1784569182269997056
author Cantù, Giulio
author_facet Cantù, Giulio
author_sort Cantù, Giulio
collection PubMed
description The purpose of this review is to analyse the very large number of studies (sometimes contradictory) on adenoid cystic carcinoma (ACC). This second part provides a critical analysis of various treatment described in the literature. Anywhere the primary tumour is located, the most common treatment for ACC is complete surgical resection, with or without post-operative radiotherapy (PORT), while conventional photon and/or electron radiotherapy alone and chemotherapy are commonly used in unresectable or metastatic disease. Fast neutron radiotherapy was used in the past with good local results, but the risk of late effects was high and tended to increase over time. Modern carbon-ion radiotherapy seems to be a valid option in selected cases. The quite universally accepted poor prognostic factors are advanced stage, perineural and intraneural invasion, involved margins, and initial presence or later development of neck metastases. The impact of histologic grade on prognosis is controversial. Owing to the long natural history of ACC, the follow-up for patients must be at least 10 years long.
format Online
Article
Text
id pubmed-8448184
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Pacini Editore Srl
record_format MEDLINE/PubMed
spelling pubmed-84481842021-09-29 Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis Cantù, Giulio Acta Otorhinolaryngol Ital Review The purpose of this review is to analyse the very large number of studies (sometimes contradictory) on adenoid cystic carcinoma (ACC). This second part provides a critical analysis of various treatment described in the literature. Anywhere the primary tumour is located, the most common treatment for ACC is complete surgical resection, with or without post-operative radiotherapy (PORT), while conventional photon and/or electron radiotherapy alone and chemotherapy are commonly used in unresectable or metastatic disease. Fast neutron radiotherapy was used in the past with good local results, but the risk of late effects was high and tended to increase over time. Modern carbon-ion radiotherapy seems to be a valid option in selected cases. The quite universally accepted poor prognostic factors are advanced stage, perineural and intraneural invasion, involved margins, and initial presence or later development of neck metastases. The impact of histologic grade on prognosis is controversial. Owing to the long natural history of ACC, the follow-up for patients must be at least 10 years long. Pacini Editore Srl 2021-09-14 2021-08 /pmc/articles/PMC8448184/ /pubmed/34533533 http://dx.doi.org/10.14639/0392-100X-N1729 Text en Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) license. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
spellingShingle Review
Cantù, Giulio
Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis
title Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis
title_full Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis
title_fullStr Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis
title_full_unstemmed Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis
title_short Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis
title_sort adenoid cystic carcinoma. an indolent but aggressive tumour. part b: treatment and prognosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448184/
https://www.ncbi.nlm.nih.gov/pubmed/34533533
http://dx.doi.org/10.14639/0392-100X-N1729
work_keys_str_mv AT cantugiulio adenoidcysticcarcinomaanindolentbutaggressivetumourpartbtreatmentandprognosis